Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

09 avr. 2026 16h40 HE | Source: Beam Global

Beam Global Reports Full Year 2025 Operating Results

Beam Global reports 2025 results: Q4 revenue +56% QoQ, strong shift to commercial & international markets, improved margins, debt-free balance sheet.
08 avr. 2026 18h19 HE | Source: Beam Global

Beam Global to Release 2025 Operating Results, Conference Call Scheduled for April 09, 2026 at 4:30 p.m. ET

Beam Global to report 2025 results April 9, 2026, with a 4:30 p.m. ET call covering financial performance, updates, and a live Q&A session for investors.
05 mars 2026 01h51 HE | Source: Cabka N.V.

Cabka delivers disciplined SHIFT execution in 2025 with EBITDA growth and significant net debt reduction

Key Financial Developments 2025 Revenues of €180.0 million, down 1% yoy (2024: €181.9 million), with improved momentum in H2Gross margin improved to 51.3% (2024: 50.9%), due to an improved product...
09 déc. 2025 06h45 HE | Source: Castellum, Inc.

Castellum, INC.’s CEO Provides Its Shareholders a Corporate Update

CASTELLUM, INC.’s CEO PROVIDES ITS SHAREHOLDERS A CORPORATE UPDATE
12 mars 2025 06h30 HE | Source: Centogene NV

CENTOGENE Closes Strategic Transaction with Private Equity Group Charme Capital Partners

CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, March 12, 2025 (GLOBE NEWSWIRE) -- Centogene N.V. (OTC: CNTGF) (“CENTOGENE” or the “Company”) today announced it has closed its transaction to sell...
27 avr. 2023 07h40 HE | Source: HCW Biologics, Inc

HCW Biologics Secures $26.25 Million Non-Dilutive Financing With Asset-Backed Development Loan

Provides funding for buildout of new headquarters and manufacturing facility Capital requirements now funded into 2025 MIRAMAR, Fla., April 27, 2023 (GLOBE NEWSWIRE) -- HCW Biologics Inc. (the...